Cannabis cultivation as a business

TL;DR

• Industrial hemp (<1 % THC): allowed, thin margins (~CHF 5–10/kg fiber).
• Indoor CBD flower: CHF 3–8/g wholesale, high energy costs.
• EU-GMP cultivation for medical: CHF 5–15/g, investment >CHF 5 M.
• Scaling only viable with major offtake contracts.

Indoor cost structure

• Electricity: 40–50 % of OPEX (HPS 600W → LED 400W reduces).
• Rent/build-out: 15–25 %.
• Staff (grower, trimmer): 15–20 %.
• Nutrients, substrate, packaging: 5–10 %.
• Compliance/analytics (HPLC tests): 3–5 %.

Cost structure of a Swiss grow: why electricity and labour decide the margin

An indoor operation in Switzerland faces two cost blocks that barely compare internationally: electricity and wages. Lighting, dehumidification and climate control make up the largest variable share; switching from HPS to modern LED cuts consumption markedly and simultaneously lowers cooling load, so the effect compounds. Labour costs hit hardest in post-harvest – trimming is the most expensive step in the cycle, and that is where machine trimming with slight quality loss competes against hand work with a premium markup.

The strategic consequence is clear: Swiss operations rarely win on volume, but on quality, traceability and Swissness. Greenhouse or outdoor production slashes energy costs but yields less consistent profiles and depends on weather. Indoor growers must justify the premium through batch analytics, stable terpene profiles, careful drying and documented GACP processes – otherwise they compete with imports on a cost level they cannot win.

• Energy and trimming are the two biggest controllable cost blocks – optimise there first.
• LED cuts consumption and cooling load at once; payback usually within a few cycles.
• Greenhouse/outdoor: lower cost, variable profiles – often the better fit for extracts.
• Premium pricing only with evidence: batch analytics, GACP documentation, consistent terpenes.

Regulatory hurdles and authority jurisdictions

Anyone wishing to cultivate cannabis for commercial purposes in Switzerland must navigate a complex web of federal authorities and cantonal offices. Since August 2022, medical cannabis can be prescribed by doctors without an exceptional permit from the FOPH, opening up new market opportunities. Nevertheless, the cultivation of plants with a total THC content of over one percent is subject to strict controls by Swissmedic and the Federal Office of Public Health (FOPH). For the cultivation of CBD hemp with less than one percent THC, which is not classified as a narcotic, the Federal Office for Agriculture (FOAG) and cantonal agricultural offices are responsible.

Compliance with legal requirements requires seamless documentation from sowing to distribution. Businesses must prove that their products strictly comply with the limit values, as exceeding the THC threshold of one percent entails criminal consequences under the Narcotics Act (BetmG). Furthermore, cantonal differences in enforcement play a significant role. While some cantons have established simplified reporting procedures for CBD cultivation, others demand detailed operational concepts and conduct regular, unannounced on-site inspections to collect samples for laboratory analysis.

• Jurisdiction of Swissmedic for medical cannabis and the Federal Office of Public Health (FOPH) for fundamental regulatory issues.
• Strict compliance with the limit of one percent total THC to differentiate from the illegal narcotics sector.
• Cantonal differences in enforcement and reporting deadlines for agricultural holdings.
• Necessity of regular laboratory analyses to ensure legal compliance.

Quality standards in medical cultivation: GACP and EU-GMP

For Swiss producers aiming for the medical cannabis market, there is no way around international quality standards. The Good Agricultural and Collection Practice (GACP) guidelines form the foundation for the agricultural part of production. They regulate everything from seed quality and the use of fertilizers to staff training. Since medical cannabis serves as a starting material for medicinal products, contamination by heavy metals, pesticides, or microorganisms must be consistently ruled out. This requires cleanroom technologies and strictly controlled processes.

As soon as the harvest is processed, dried, or packaged, the even stricter Good Manufacturing Practice (GMP) guidelines apply. Swiss companies pushing into the export market must often be able to demonstrate EU-GMP certification. This step requires seamless traceability of every single batch and comprehensive validation of all technical equipment. Any deviation in the production process must be documented and analyzed. The administrative effort for quality assurance in such operations often exceeds the actual horticultural effort, but it represents the only ticket to the medical market.

• GACP as an indispensable foundation for the controlled cultivation and harvesting of medical plants.
• EU-GMP certification as a prerequisite for export and further processing into medicinal products.
• Prevention of contamination through strict hygiene plans and controlled ventilation systems.
• Seamless batch traceability to ensure patient safety and product consistency.

Risk management for pest infestations and crop failures

Commercial cannabis cultivation carries significant biological and technical risks that can pose an existential threat to the economic viability of an operation. In closed indoor facilities, monocultures under warm, humid conditions create an ideal breeding ground for pests such as spider mites, thrips, or fungus gnats. Since the use of chemical plant protection products is extremely restricted or completely prohibited, particularly in the medical sector and for CBD flowers, operations must rely on biological pest control. The preventive use of beneficial insects and meticulous hygiene are therefore standard in professional Swiss facilities.

In addition to biological hazards, technical failures represent a critical risk. A failure of the ventilation or air conditioning system lasting several hours during the flowering phase can destroy the entire harvest due to mould formation, particularly Botrytis. Swiss operations must therefore invest in redundant power supply and climate control systems. The disposal of faulty batches or waste is also subject to strict regulations. For THC-containing material, destruction must take place under supervision or in accordance with clear regulatory requirements to prevent misuse and avoid environmental impact.

• Biological pest control using beneficial insects as a replacement for prohibited chemical pesticides.
• Redundant climate control and ventilation systems to prevent mould formation and crop losses.
• Strict regulatory requirements for the disposal and destruction of non-marketable plant material.
• Preventive hygiene locks and employee training to minimize the introduction of pathogens.

Site selection and infrastructural requirements in Switzerland

In Switzerland, choosing the right location is a decisive factor in the long-term success of a cultivation facility. In addition to pure rental or land costs, zoning regulations play a crucial role. Cultivation in agricultural zones is subject to strict conditions, whereas establishing operations in industrial zones is often easier to approve but incurs higher development costs. Furthermore, operators must carefully assess the local infrastructure. High water consumption and the massive electrical load for lighting and climate control require a correspondingly dimensioned grid connection, the expansion of which can be time-consuming and costly.

An often underestimated factor in site selection is odour emission. Despite modern active carbon filters, noticeable odours can occur in the vicinity of large-scale facilities, regularly leading to complaints from local residents. Swiss municipalities therefore require detailed ventilation and odour concepts during the building permit process. The security requirements of the cantons must also not be neglected. Particularly for facilities producing within the framework of state-controlled pilot trials under BetmG Article 8b, the authorities require mechanical and electronic security systems to effectively prevent unauthorized access and theft.

• Consideration of cantonal and municipal zoning plans during site evaluation.
• Assessment of local electrical grid capacities to avoid expensive infrastructure upgrades.
• Creation of professional odour control concepts to comply with environmental protection regulations and avoid conflicts with neighbours.
• Integration of high security standards such as video surveillance and access controls in accordance with official requirements.

FAQ